Abiopharma

New Form SCHEDULE 13G - URANIUM ENERGY CORP <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000305 <b>Size:</b> 8 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001839882-26-023737 <b>Size:</b> 341 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001839882-26-023736 <b>Size:</b> 478 KB

bioAffinity Technologies Reports Record MonthlyCyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

TD SYNNEX Accelerates Investment in U.S. Public Sector Business at Annual Red, White & You Event

SU Group Announces Pricing of $6 Million Public Offering

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

Republic Partners adopts Intapp DealCloud to unify deal management and client relationships

Algorhythm Holdings to Announce its Financial Results for the First Quarter of 2026

New Form SCHEDULE 13G - UNITED COMMUNITY BANKS INC <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000304 <b>Size:</b> 8 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001839882-26-023735 <b>Size:</b> 356 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000950103-26-007085 <b>Size:</b> 615 KB

New Form SCHEDULE 13G - uniQure N.V. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000303 <b>Size:</b> 8 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001213900-26-054916 <b>Size:</b> 2 MB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001839882-26-023734 <b>Size:</b> 482 KB